The endocannabinoid system (ECS) plays an important role in the pathophysiology of psychotic disorders. Hemp cannabinoids have the ability to regulate the functioning of this system, which is why the potential antipsychotic properties of CBD are the subject of scientific research in many research centers around the world. Researchers are paying attention to different types and stages of psychotic disorders (including schizophrenia). They are also testing the potential benefits of CBD use in people who experience psychotic episodes in the course of other diseases, such as Parkinson's disease. Let's take a look at a selection of study results.
